Lexipafant | Interleukin Related interleukin-related.com

Product Name :
Lexipafant

Search keywords :
Lexipafant

drugId :
null

Target Vo:
Platelet-activating factor

Target Vo Short Name :
Platelet-activating factor

Moa_Name:
Platelet-activating factor inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Vernalis Plc

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Pancreatitis

Termination Status :
NDA/BLA

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Phospho-Chk1 (Ser296) Antibody
PDCD4 Antibody
p300 Antibody: p300 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 264 kDa, targeting to p300. It can be used for ICC/IF,WB,IHC-F,IHC-P,ELISA assays with tag free, in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts